Fluocinolone acetonide/hydroquinone/tretinoin - Hill Dermaceuticals
Alternative Names: Hydroquinone/tretinoin/fluocinolone-acetonide; Tri-LumaLatest Information Update: 11 Feb 2019
At a glance
- Originator Hill Dermaceuticals
- Developer Galderma
- Class Fluorinated steroids; Hydroquinones; Pregnadienes; Retinoids; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Melanosis
Most Recent Events
- 11 Feb 2019 Chemical structure information added
- 10 Apr 2003 Data presented at the 61st Annual Meeting of the American Academy of Dermatology (AAD-2003) have been added to the adverse events and Skin Disorders therapeutic trials section
- 29 Apr 2002 Data from a media release have been added to the adverse events and Skin disorders therapeutic trials sections